Volume 54, Issue 2 pp. 1279-1286
Article

Synthesis and Pharmacological Evaluation of Novel Pyrazolyl Piperidine Derivatives as Effective Antiplatelet Agents

Jigar Y. Soni

Jigar Y. Soni

Department of Chemistry, Faculty of Science, The M. S. University of Baroda, Vadodara, 390 002 India

Search for more papers by this author
Riyaj S. Tamboli

Riyaj S. Tamboli

Pharmacy Department, Faculty of Technology and Engineering, Kalabhavan, The M. S. University of Baroda, Vadodara, 390 001 India

Search for more papers by this author
Rajani Giridhar

Rajani Giridhar

Pharmacy Department, Faculty of Technology and Engineering, Kalabhavan, The M. S. University of Baroda, Vadodara, 390 001 India

Search for more papers by this author
Mange Ram Yadav

Mange Ram Yadav

Pharmacy Department, Faculty of Technology and Engineering, Kalabhavan, The M. S. University of Baroda, Vadodara, 390 001 India

Search for more papers by this author
Sonal Thakore

Corresponding Author

Sonal Thakore

Department of Chemistry, Faculty of Science, The M. S. University of Baroda, Vadodara, 390 002 India

E-mail: [email protected]Search for more papers by this author
First published: 15 June 2016
Citations: 2

Abstract

The synthesis and antiplatelet activity of substituted pyrazolyl piperidine derivatives (3a–n) are described. These compounds were synthesized by an improved ring opening reaction of 2-arylidene quinuclidinone using hydrazine hydrate under mild conditions. They were characterized and screened for their in vitro antiplatelet profile in human platelet aggregation using adenosine diphosphate as agonist. Investigation of structure activity relation revealed interesting results. Among these synthesized derivatives (3a–n), compounds 3a, 3c, 3j, and 3l exhibited excellent activity, while 3c was the most potent one. Based on IC50 values, it was observed that most of the compounds possessed antiplatelet aggregation activity superior to the reference drug Aspirin.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.